94 related articles for article (PubMed ID: 23160377)
1. Doxorubicin promotes transcriptional upregulation of Cdc25B in cancer cells by releasing Sp1 from the promoter.
Dalvai M; Mondesert O; Bugler B; Manenti S; Ducommun B; Dozier C
Oncogene; 2013 Oct; 32(42):5123-8. PubMed ID: 23160377
[TBL] [Abstract][Full Text] [Related]
2. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors.
Dalvai M; Mondesert O; Bourdon JC; Ducommun B; Dozier C
Oncogene; 2011 May; 30(19):2282-8. PubMed ID: 21242964
[TBL] [Abstract][Full Text] [Related]
3. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest.
Manni I; Mazzaro G; Gurtner A; Mantovani R; Haugwitz U; Krause K; Engeland K; Sacchi A; Soddu S; Piaggio G
J Biol Chem; 2001 Feb; 276(8):5570-6. PubMed ID: 11096075
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
5. Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.
Bugler B; Quaranta M; Aressy B; Brezak MC; Prevost G; Ducommun B
Mol Cancer Ther; 2006 Jun; 5(6):1446-51. PubMed ID: 16818502
[TBL] [Abstract][Full Text] [Related]
6. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulation of the murine cdc25B promoter: essential role for nuclear factor-Y and a proximal repressor element.
Körner K; Jerôme V; Schmidt T; Müller R
J Biol Chem; 2001 Mar; 276(13):9662-9. PubMed ID: 11104768
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery.
Jullien D; Bugler B; Dozier C; Cazales M; Ducommun B
Cancer Res; 2011 Mar; 71(5):1968-77. PubMed ID: 21363925
[TBL] [Abstract][Full Text] [Related]
9. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.
van der Watt PJ; Leaner VD
Biochim Biophys Acta; 2011 Jul; 1809(7):316-26. PubMed ID: 21683812
[TBL] [Abstract][Full Text] [Related]
10. Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents.
Aressy B; Bugler B; Valette A; Biard D; Ducommun B
Cell Cycle; 2008 Jul; 7(14):2234-40. PubMed ID: 18635965
[TBL] [Abstract][Full Text] [Related]
11. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
12. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.
Ru Lee W; Chen CC; Liu S; Safe S
J Cell Biochem; 2006 Sep; 99(1):209-20. PubMed ID: 16598773
[TBL] [Abstract][Full Text] [Related]
13. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
14. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
Lu S; Archer MC
Int J Cancer; 2010 Jan; 126(2):416-25. PubMed ID: 19621387
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia.
Nakamura S; Nagata Y; Tan L; Takemura T; Shibata K; Fujie M; Fujisawa S; Tanaka Y; Toda M; Makita R; Tsunekawa K; Yamada M; Yamaoka M; Yamashita J; Ohnishi K; Yamashita M
PLoS One; 2011; 6(11):e28011. PubMed ID: 22132193
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.
Giono LE; Resnick-Silverman L; Carvajal LA; St Clair S; Manfredi JJ
Oncogene; 2017 Dec; 36(49):6762-6773. PubMed ID: 28806397
[TBL] [Abstract][Full Text] [Related]
17. Induction of Cdc25B regulates cell cycle resumption after genotoxic stress.
Bansal P; Lazo JS
Cancer Res; 2007 Apr; 67(7):3356-63. PubMed ID: 17409445
[TBL] [Abstract][Full Text] [Related]
18. Stress-activated mitogen-activated protein kinases c-Jun NH2-terminal kinase and p38 target Cdc25B for degradation.
Uchida S; Yoshioka K; Kizu R; Nakagama H; Matsunaga T; Ishizaka Y; Poon RY; Yamashita K
Cancer Res; 2009 Aug; 69(16):6438-44. PubMed ID: 19638579
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.
Shirley SH; Rundhaug JE; Tian J; Cullinan-Ammann N; Lambertz I; Conti CJ; Fuchs-Young R
Cancer Res; 2009 Apr; 69(8):3405-14. PubMed ID: 19351845
[TBL] [Abstract][Full Text] [Related]
20. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
Miyata H; Doki Y; Shiozaki H; Inoue M; Yano M; Fujiwara Y; Yamamoto H; Nishioka K; Kishi K; Monden M
Clin Cancer Res; 2000 Dec; 6(12):4859-65. PubMed ID: 11156245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
